BioCentury | Nov 17, 2003
Company News

Paladin, PanGeo sales and marketing update

...Paladin Labs Inc. (TSE:PLB), Montreal, Quebec PanGeo Pharma Inc. (TSE:PIL), Montreal, Quebec Business: Cardiovascular, Neurology, Inflammation PLB will...
BioCentury | Mar 24, 2003
Company News

PanGeo board of directors update

PanGeo Pharma Inc. (TSE:PIL), Montreal, Quebec Business: Supply/Service Appointed: Gary Ullman, formerly president and CEO of Unitron Industries Ltd.; and Jim Youmans, director at Diabetogen Biosciences Inc. Resigned: Daniel Pharand; David Appel; and Bob Goodwin...
BioCentury | Dec 9, 2002
Company News

PanGeo, Novartis deal

...is indicated as an add-on medication in the chronic treatment of mild atopic asthmatic children. PanGeo Pharma Inc....
BioCentury | Nov 4, 2002
Company News

PanGeo, Sorm Co. deal

...also completed its acquisition of a minority share interest in Sorm (see BioCentury, March 25). PanGeo Pharma Inc....
BioCentury | Mar 25, 2002
Company News

PanGeo, Sorm Co. deal

...2001 deal, PIL supplies its non-prescription pharmaceutical products to Sorm for exclusive distribution in Japan. PanGeo Pharma Inc....
BioCentury | Aug 27, 2001
Company News

Cellegy, PanGeo deal

...trials in the U.S. to treat male hypogonadism. Cellegy Pharmaceuticals Inc. (CLGY), South San Francisco, PanGeo Pharma Inc....
BioCentury | Aug 21, 2001
Company News

CLGY, PIL manufacturing deal

PanGeo Pharma (TSE:PIL) will manufacture Tostrex testosterone gel, which is in Phase III trials to treat male hypogonadism, for Cellegy (CLGY). BC Staff...
BioCentury | Jun 11, 2001
Company News

PanGeo management update

PanGeo Pharma Inc. (TSE:PIL), Montreal, Quebec Business: Supply/Service Promoted: Sean Cleary to president from CFO; and Alex Del Vecchio to CFO from VP of finance WIR Staff...
BioCentury | Aug 7, 2000
Company News

Pharmex Industries Inc., Novopharm Ltd. deal

...Wampole Canada Inc. (Toronto, Ontario) for $14.6 million in cash. Novopharm Quebec will be renamed PanGeo...
Items per page:
1 - 9 of 9
BioCentury | Nov 17, 2003
Company News

Paladin, PanGeo sales and marketing update

...Paladin Labs Inc. (TSE:PLB), Montreal, Quebec PanGeo Pharma Inc. (TSE:PIL), Montreal, Quebec Business: Cardiovascular, Neurology, Inflammation PLB will...
BioCentury | Mar 24, 2003
Company News

PanGeo board of directors update

PanGeo Pharma Inc. (TSE:PIL), Montreal, Quebec Business: Supply/Service Appointed: Gary Ullman, formerly president and CEO of Unitron Industries Ltd.; and Jim Youmans, director at Diabetogen Biosciences Inc. Resigned: Daniel Pharand; David Appel; and Bob Goodwin...
BioCentury | Dec 9, 2002
Company News

PanGeo, Novartis deal

...is indicated as an add-on medication in the chronic treatment of mild atopic asthmatic children. PanGeo Pharma Inc....
BioCentury | Nov 4, 2002
Company News

PanGeo, Sorm Co. deal

...also completed its acquisition of a minority share interest in Sorm (see BioCentury, March 25). PanGeo Pharma Inc....
BioCentury | Mar 25, 2002
Company News

PanGeo, Sorm Co. deal

...2001 deal, PIL supplies its non-prescription pharmaceutical products to Sorm for exclusive distribution in Japan. PanGeo Pharma Inc....
BioCentury | Aug 27, 2001
Company News

Cellegy, PanGeo deal

...trials in the U.S. to treat male hypogonadism. Cellegy Pharmaceuticals Inc. (CLGY), South San Francisco, PanGeo Pharma Inc....
BioCentury | Aug 21, 2001
Company News

CLGY, PIL manufacturing deal

PanGeo Pharma (TSE:PIL) will manufacture Tostrex testosterone gel, which is in Phase III trials to treat male hypogonadism, for Cellegy (CLGY). BC Staff...
BioCentury | Jun 11, 2001
Company News

PanGeo management update

PanGeo Pharma Inc. (TSE:PIL), Montreal, Quebec Business: Supply/Service Promoted: Sean Cleary to president from CFO; and Alex Del Vecchio to CFO from VP of finance WIR Staff...
BioCentury | Aug 7, 2000
Company News

Pharmex Industries Inc., Novopharm Ltd. deal

...Wampole Canada Inc. (Toronto, Ontario) for $14.6 million in cash. Novopharm Quebec will be renamed PanGeo...
Items per page:
1 - 9 of 9